Fundz

Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

PRIVATEDec 12, 2023

Position

President Of U.S. Operations

Company

Alimera

Todd Wood
todd.wood@alimerasciences.com
AtlantaHealthcarePharmaceutical Manufacturing

Description

Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced the appointment of Todd Wood as President U.S. effective immediately.

Quick answer

Alimera Sciences Appoints Todd Wood as President of U.S. Operations and Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) (December 12, 2023). Alimera is based in Atlanta, Georgia, United States.

Who is the new President Of U.S. Operations at Alimera?
Alimera named Todd Wood President Of U.S. Operations, announced December 12, 2023.
What did Alimera announce on December 12, 2023?
Alimera Sciences, Inc. , a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health, and maintaining better vision longer, today announced the appointment of Todd Wood as President U.S. effective immediately.
What does Alimera do?
Alimera Sciences, Inc. is a global pharmaceutical company dedicated to being invaluable to patients, physicians, and partners by maintaining better vision for a longer time.
Where is Alimera based?
Alimera is based in Atlanta, Georgia, United States.
Which similar companies made leadership changes around the same time?
Elligo Health Research, Inc. (December 19, 2023), Mirum Pharmaceuticals, Inc. (January 16, 2024) and Tris Pharma (January 22, 2024) also announced leadership changes within 45 days of Alimera.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Pharmaceutical Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Alimera, and when

A new leader at Alimera brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Alimera raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Alimera, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Alimera. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Alimera

Location

6310 Town Square

Atlanta, Georgia, United States

About

Alimera Sciences, Inc. is a global pharmaceutical company dedicated to being invaluable to patients, physicians, and partners by maintaining better vision for a longer time. The company's primary focus is on treating diabetic macular edema (DME) and chronic non-infectious uveitis affecting the posterior segment of the eye. Alimera's commercial products, ILUVIEN and YUTIQ, have significant growth potential and are expected to add approximately $105 million in highly durable branded revenue to ANI's portfolio. The acquisition by ANI is expected to create compelling value for Alimera's shareholders and provide a bigger platform to leverage its global infrastructure and outstanding team.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Alimera changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Richard
Likely contact at this company
••••••••@••••••••

See Richard's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Alimera's next move

Learn about Strategic plan

Alimera changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.